IL314684A - Methods for losing weight and preserving skeletal muscle mass - Google Patents

Methods for losing weight and preserving skeletal muscle mass

Info

Publication number
IL314684A
IL314684A IL314684A IL31468424A IL314684A IL 314684 A IL314684 A IL 314684A IL 314684 A IL314684 A IL 314684A IL 31468424 A IL31468424 A IL 31468424A IL 314684 A IL314684 A IL 314684A
Authority
IL
Israel
Prior art keywords
methods
weight loss
skeletal muscle
muscle mass
preserving
Prior art date
Application number
IL314684A
Other languages
English (en)
Hebrew (he)
Inventor
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Original Assignee
Rivus Pharmaceuticals Inc
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivus Pharmaceuticals Inc, Shaharyar Khan, Diane Jorkasky, Francisco Portell filed Critical Rivus Pharmaceuticals Inc
Publication of IL314684A publication Critical patent/IL314684A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL314684A 2022-02-07 2023-02-06 Methods for losing weight and preserving skeletal muscle mass IL314684A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US202263382456P 2022-11-04 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (1)

Publication Number Publication Date
IL314684A true IL314684A (en) 2024-10-01

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314684A IL314684A (en) 2022-02-07 2023-02-06 Methods for losing weight and preserving skeletal muscle mass

Country Status (12)

Country Link
US (1) US20250134864A1 (cg-RX-API-DMAC7.html)
EP (1) EP4475841A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505187A (cg-RX-API-DMAC7.html)
KR (1) KR20240146052A (cg-RX-API-DMAC7.html)
AU (1) AU2023216366A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243640A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002341A1 (cg-RX-API-DMAC7.html)
GE (1) GEAP202416578A (cg-RX-API-DMAC7.html)
IL (1) IL314684A (cg-RX-API-DMAC7.html)
JO (1) JOP20240177A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024009646A (cg-RX-API-DMAC7.html)
WO (1) WO2023150767A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Also Published As

Publication number Publication date
JP2025505187A (ja) 2025-02-21
AU2023216366A1 (en) 2024-08-15
GEAP202416578A (en) 2024-11-11
MX2024009646A (es) 2024-11-08
CL2024002341A1 (es) 2025-01-17
WO2023150767A1 (en) 2023-08-10
CA3243640A1 (en) 2023-08-10
KR20240146052A (ko) 2024-10-07
JOP20240177A1 (ar) 2024-08-04
EP4475841A1 (en) 2024-12-18
US20250134864A1 (en) 2025-05-01

Similar Documents

Publication Publication Date Title
EP4210713A4 (en) SKELETAL MUSCLE RELEASE PLATFORMS AND METHODS OF USE
SG11202107701VA (en) Isolation and cultivation of muscle and fat cells from crustaceans
FI4126066T3 (fi) Koostumuksia ja menetelmiä lihasdystrofian hoitoon
GB2581744B (en) Weight rack system and methods of making and using same
IL315862A (en) Angiotensinogen modulators and methods of using them
GB2613253B (en) Preparation for improving survival rate of colored-leaf poplar and application thereof
HK40119961A (en) Methods of weight loss and preserving skeletal muscle mass
GB202319843D0 (en) CAS13-based compositions and methods of use thereof
MX2024009646A (es) Métodos de pérdida de peso y preservación de la masa muscular esquelética.
IL311518A (en) Preparations that modulate perkalkerine and methods of using them
GB2599284B (en) Edible paste and composition and method of preparation
CA3298873A1 (en) Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength
IL326938A (en) Methods and compositions for reducing muscle loss and/or delaying sarcopenia associated with weight loss
HK40096248A (en) Skeletal muscle delivery platforms and methods of use
CA234589S (en) Adjustable weight dumbbell
HK40111238A (en) Adeno-associated viral vector compositions and methods of promoting muscle regeneration
IL326294A (en) Apilimod compositions and methods of use
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
IL325884A (en) Gal475 compositions and methods of use thereof
NO20191178A1 (en) Exercise rucksack and method of manufacture
GB2591342B (en) Sports training aid and method of use
CA3303916A1 (en) Methods and compositions for reducing muscle loss and/or inhibiting sarcopenia associated with weight loss
GB202416890D0 (en) Packaging and method of use and/or construction thereof
ZA202200508B (en) External preparation of imidacloprid, preparation method and use thereof